155 related articles for article (PubMed ID: 27077843)
1. GL-1196 Suppresses the Proliferation and Invasion of Gastric Cancer Cells via Targeting PAK4 and Inhibiting PAK4-Mediated Signaling Pathways.
Zhang J; Zhang HY; Wang J; You LH; Zhou RZ; Zhao DM; Cheng MS; Li F
Int J Mol Sci; 2016 Apr; 17(4):470. PubMed ID: 27077843
[TBL] [Abstract][Full Text] [Related]
2. LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells.
Zhang J; Wang J; Guo Q; Wang Y; Zhou Y; Peng H; Cheng M; Zhao D; Li F
Cancer Lett; 2012 Apr; 317(1):24-32. PubMed ID: 22085492
[TBL] [Abstract][Full Text] [Related]
3. (-)-β-hydrastine suppresses the proliferation and invasion of human lung adenocarcinoma cells by inhibiting PAK4 kinase activity.
Guo B; Li X; Song S; Chen M; Cheng M; Zhao D; Li F
Oncol Rep; 2016 Apr; 35(4):2246-56. PubMed ID: 26821251
[TBL] [Abstract][Full Text] [Related]
4. Targeting PAK1 with the Small Molecule Drug AK963/40708899 Suppresses Gastric Cancer Cell Proliferation and Invasion by Downregulation of PAK1 Activity and PAK1-Related Signaling Pathways.
Zhou Y; Zhang J; Wang J; Cheng MS; Zhao DM; Li F
Anat Rec (Hoboken); 2019 Sep; 302(9):1571-1579. PubMed ID: 30773850
[TBL] [Abstract][Full Text] [Related]
5. LC-0882 targets PAK4 and inhibits PAK4-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells.
Zhang HY; Zhang J; Hao CZ; Zhou Y; Wang J; Cheng MS; Zhao DM; Li F
Am J Transl Res; 2017; 9(6):2736-2747. PubMed ID: 28670365
[TBL] [Abstract][Full Text] [Related]
6. PAK4 kinase-mediated SCG10 phosphorylation involved in gastric cancer metastasis.
Guo Q; Su N; Zhang J; Li X; Miao Z; Wang G; Cheng M; Xu H; Cao L; Li F
Oncogene; 2014 Jun; 33(25):3277-87. PubMed ID: 23893240
[TBL] [Abstract][Full Text] [Related]
7. P21 activated kinase 4 binds translation elongation factor eEF1A1 to promote gastric cancer cell migration and invasion.
Li X; Li J; Li F
Oncol Rep; 2017 May; 37(5):2857-2864. PubMed ID: 28393218
[TBL] [Abstract][Full Text] [Related]
8. Strategy and validation of a structure-based method for the discovery of selective inhibitors of PAK isoforms and the evaluation of their anti-cancer activity.
Song PL; Wang G; Su Y; Wang HX; Wang J; Li F; Cheng MS
Bioorg Chem; 2019 Oct; 91():103168. PubMed ID: 31400553
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic PAK4 regulates Smad2/3 axis involving gastric tumorigenesis.
Wang C; Li Y; Zhang H; Liu F; Cheng Z; Wang D; Wang G; Xu H; Zhao Y; Cao L; Li F
Oncogene; 2014 Jun; 33(26):3473-84. PubMed ID: 23934187
[TBL] [Abstract][Full Text] [Related]
10. MiR-199a/b-3p suppresses migration and invasion of breast cancer cells by downregulating PAK4/MEK/ERK signaling pathway.
Li SQ; Wang ZH; Mi XG; Liu L; Tan Y
IUBMB Life; 2015 Oct; 67(10):768-77. PubMed ID: 26399456
[TBL] [Abstract][Full Text] [Related]
11. DGCR6L, a novel PAK4 interaction protein, regulates PAK4-mediated migration of human gastric cancer cell via LIMK1.
Li X; Ke Q; Li Y; Liu F; Zhu G; Li F
Int J Biochem Cell Biol; 2010 Jan; 42(1):70-9. PubMed ID: 19778628
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of 1-phenanthryl-tetrahydroisoquinoline derivatives as novel p21-activated kinase 4 (PAK4) inhibitors.
Song S; Li X; Guo J; Hao C; Feng Y; Guo B; Liu T; Zhang Q; Zhang Z; Li R; Wang J; Lin B; Li F; Zhao D; Cheng M
Org Biomol Chem; 2015 Mar; 13(12):3803-18. PubMed ID: 25705811
[TBL] [Abstract][Full Text] [Related]
13. ERK1/2 signalling pathway is involved in CD147-mediated gastric cancer cell line SGC7901 proliferation and invasion.
Chen L; Pan Y; Gu L; Nie Z; He B; Song G; Li R; Xu Y; Gao T; Wang S
Exp Biol Med (Maywood); 2013 Aug; 238(8):903-12. PubMed ID: 23828593
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of PAK4 expression in gastric cancer.
Kobayashi K; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Sato Y; Yanaka Y; Higuchi K; Aburatani T; Tomii C; Uetake H; Kojima K; Kawano T
J Clin Pathol; 2016 Jul; 69(7):580-5. PubMed ID: 26614788
[TBL] [Abstract][Full Text] [Related]
15. Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer.
Zhao CC; Zhan MN; Liu WT; Jiao Y; Zhang YY; Lei Y; Zhang TT; Zhang CJ; Du YY; Gu KS; Wei W
Cancer Lett; 2020 Nov; 493():120-127. PubMed ID: 32829006
[TBL] [Abstract][Full Text] [Related]
16. Activated Pak4 expression correlates with poor prognosis in human gastric cancer patients.
Li D; Zhang Y; Li Z; Wang X; Qu X; Liu Y
Tumour Biol; 2015 Dec; 36(12):9431-6. PubMed ID: 26124003
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.
Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L
J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262
[TBL] [Abstract][Full Text] [Related]
18. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
[TBL] [Abstract][Full Text] [Related]
19. Advances in the 1-phenanthryl-tetrahydroisoquinoline series of PAK4 inhibitors: potent agents restrain tumor cell growth and invasion.
Hao C; Li X; Song S; Guo B; Guo J; Zhang J; Zhang Q; Huang W; Wang J; Lin B; Cheng M; Li F; Zhao D
Org Biomol Chem; 2016 Aug; 14(32):7676-90. PubMed ID: 27454186
[TBL] [Abstract][Full Text] [Related]
20. Oxymatrine targets EGFR(p-Tyr845) and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells.
Guo B; Zhang T; Su J; Wang K; Li X
Cancer Chemother Pharmacol; 2015 Feb; 75(2):353-63. PubMed ID: 25527205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
